The European Union has adopted new rules requiring member states to include non-price criteria such as sustainability, resilience, and project execution in renewable energy auctions.

EULAR now recommends moving directly to biologic or targeted synthetic disease-modifying antirheumatic drugs if the initial methotrexate therapy fails.

BARCELONA, Spain-- (BUSINESS WIRE)-- Hospital for Special Surgery (HSS) presented a research study at the European Alliance of Associations for Rheumatology (EULAR) Annual Meeting showing that an ...

Biogen, UCB Present Positive Phase 3 Results for Lupus Drug Candidate at EULAR 2025 Published on June 15, 2025 at 5:38 am by Maham Fatima in News ...

Three of four patients with refractory non-renal SLE achieved complete remission, she told attendees at the European Alliance of Associations for Rheumatology's (EULAR) annual meeting. She added ...

Hospital for Special Surgery (HSS) presented a research study at the European Alliance of Associations for Rheumatology (EULAR) Annual Meeting showing that an artificial intelligence (AI)-based ...

BARCELONA, Spain-- (BUSINESS WIRE)-- Hospital for Special Surgery (HSS) presented new findings at the European Alliance of Associations for Rheumatology (EULAR) Annual Meeting that could help pave the ...

BIMZELX® (bimekizumab-bkzx) Three-Year Data at EULAR 2025 Showed Lasting Efficacy and Control of Inflammation in Psoriatic Arthritis and Axial Spondyloarthritis ...

EULAR – The European Alliance of Associations for Rheumatology – the leading organisation for rheumatic and musculoskeletal diseases (RMDs) in Europe is delighted to welcome Professor Xenofon ...